Reliable
AccuGel 29:1 is a stable, ready-to-use solution of 40% (w/v) acrylamide:bisacrylamide (29:1). AccuGel 29:1 has zero acrylic acid content, which eliminates the fixed charges that cause band streaking. Additionally, oxidation products such as aldehydes have been removed by a selective adsorption process. With AccuGel 29:1, you can be confident that your results will be consistent from one electrophoretic run to the next.
better security
AccuGel 29:1 reduces exposure to neurotoxic acrylamide dust by eliminating the need to handle and weigh solid acrylamide and methylene biacrylamide, which often leads to airborne particulates that can be easily inhaled. For your safety, AccuGel 29:1 is supplied in PVC coated shatter-proof bottles.
Accu Gels
stable and pure
AccuGel 29:1 is stable for 24 months when stored tightly closed in a dark area at room temperature. Potential Health Effects Breathing
Inhalation of mist causes irritation in the respiratory tract. Symptoms may be parallel ingestion. ingestion
Toxic! May cause systemic toxicity. Drowsiness, tingling sensation, tiredness, weakness, stumbling, slurred speech, and tremors may occur.
There may be damage to the central and peripheral nervous systems. Severe intoxication can cause permanent nerve damage. Reproduction
Can affect the system and act as a teratogen. in the skin
Burning and redness may occur. Can be absorbed through the skin causing systemic toxicity; Symptoms may be parallel ingestion. Eyes
Acrylamide solution may cause eye irritation.
carcinogenicity
Acrylamide is considered a cancer risk factor. Can cause cancer. Listed by NTP as a suspected carcinogen. Acrylamide is known to cause cancer in the state of California. mutagenicity
Acrylamide was negative both with and without metabolic activation in the Ames assay. reproductive toxicity
Acrylamide-induced male reproductive toxicity has been demonstrated in Long-Evans rats where greater than or equal to 15 mg/kg/day of acrylamide is given orally by gavage for five consecutive days. In this study, males receiving greater than or equal to 15 mg/kg/day acrylamide had a lower fertility index.
